Virscio, Inc.
New Haven, CT
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5 Science Park #3, New Haven, CT 06511, USA
- Website
- virscio.com
- Founded
- 2002
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $607,938 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $607,938 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Neural stem support | Veterans Integrated Service Network 4 (VHA) | $422,030 | |
| Histological analysis of H9 | Veterans Integrated Service Network 22 (VHA) | $185,908 | |
| EO MOD 14398 | Veterans Integrated Service Network 22 (VHA) | $0 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Virscio, Inc., a for-profit biotechnology research company based in New Haven, Connecticut, provides cGLP-compliant histopathology, biomarker development, and nonclinical toxicology services to federal health agencies as a prime contractor, with all recent awards held directly (100% prime footprint) and no subcontract engagement.
Virscio's work centers on preclinical research support for regenerative medicine and aging biology. Recent prime awards include three purchase orders from the Department of Veterans Affairs Veterans Integrated Service Network 22 totaling $664 thousand: a $422,030 order (September 2026) for cGLP-compliant histopathology services supporting a nonclinical toxicology study of intraspinal H9 spinal cord neural stem cell administration in cervical spinal cord injury; a $185,908 order (June 2026) for histological analysis of H9 cells; and a $55,861 order (May 2026) for related work. All three VA orders are performed in San Diego, California, with completion dates running through September 2027. The company also holds a $291,913 Project Grant from the National Institute on Aging (CFDA 93.866), awarded September 2025 and targeted for completion September 2026, to develop epigenetic and senescent cell biomarkers derived from nonhuman primate tissues to advance aging science and anti-aging therapeutic strategies, with focus on DNA methylation analysis and epigenetic "clocks" in blood and skin samples.
Customer concentration is fragmented across the federal research and health enterprise. The Veterans Integrated Service Network 22 (a component of the Department of Veterans Affairs Veterans Health Administration) holds 100% of disclosed awards by potential value, though the National Institutes of Health, including the National Institute on Aging and the Office of the Director, account for two awards each on the grant side. The vendor's award footprint is sparse and irregular — one award in 2013, one in 2017, one in 2020, then acceleration to one in 2025 and three in 2026 — with all three active awards (combined potential value $664 thousand) completing within the next twenty-four months and therefore at recompete risk. Obligated dollars ($6.9 million) exceed potential value by more than ten times, reflecting prior year invoiced revenue and earlier completed work not enumerated in the source. Virscio competes in full-and-open, non-set-aside categories under NAICS codes spanning testing laboratories, biotechnology R&D, and life sciences research and development.
Quick answers
Is Virscio, Inc. registered in SAM.gov?
Yes. Virscio, Inc.'s SAM.gov registration is active through December 8, 2026.
What is Virscio, Inc.'s CAGE code?
Virscio, Inc.'s CAGE code is 4A9M1, and its Unique Entity ID (UEI) is EYCBWGA47PL5.
How much has Virscio, Inc. received in federal contracts?
Federal contracts obligated $607,938 to Virscio, Inc. in fiscal years 2023 through 2027.
What is Virscio, Inc.'s most recent federal award?
Virscio, Inc.'s most recent federal contract award is Neural stem support (36C24E26P0070), from Veterans Integrated Service Network 4 (VHA), on September 28, 2026.
On GovTribe
See Virscio, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors